Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -ZAR 56.4B, followed by BridgeBio Pharma (-ZAR 36B) and Cytokinetics (-ZAR 11.4B). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-ZAR 56.4B
- Median
- ZAR 15.1B
- Combined market value
- ZAR 87.67T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -ZAR 56.4B | ZAR 8.79T | ZAR 4,971.48 | 1.50% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -ZAR 36B | ZAR 261.8B | ZAR 1,343.69 | 1.50% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -ZAR 11.4B | ZAR 123.1B | ZAR 883.58 | 0.76% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -ZAR 3.5B | ZAR 87.2B | ZAR 1,043.71 | 0.31% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -ZAR 3.1B | ZAR 305.8B | ZAR 4,661.98 | 0.27% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -ZAR 2.1B | ZAR 90.7B | ZAR 2,150.35 | 0.71% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -ZAR 1.2B | ZAR 129.8B | ZAR 372.67 | 2.37% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | ZAR 1.5B | ZAR 121.1B | ZAR 2,302.72 | 1.74% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | ZAR 2B | ZAR 83.2B | ZAR 867.21 | 1.55% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 2.4B | ZAR 139.4B | ZAR 2,011.33 | 0.06% up | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.4B | ZAR 103.1B | ZAR 1,578.67 | 0.40% down | 31% up | ||
| 12 | ErascaERAS · Health Care | ZAR 5.6B | ZAR 80.2B | ZAR 228.39 | 4.61% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | ZAR 5.7B | ZAR 67.2B | ZAR 491.09 | 3.03% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 8B | ZAR 105.9B | ZAR 748.96 | 1.07% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | ZAR 8.1B | ZAR 113B | ZAR 1,665.98 | 0.34% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | ZAR 8.4B | ZAR 78.3B | ZAR 470.23 | 1.19% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | ZAR 8.5B | ZAR 83.9B | ZAR 1,489.90 | 0.63% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | ZAR 8.7B | ZAR 126.2B | ZAR 1,441.81 | 1.88% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9B | ZAR 77B | ZAR 702.89 | 3.00% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 9.8B | ZAR 130.3B | ZAR 1,658.91 | 1.19% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 10.4B | ZAR 164.9B | ZAR 7,098.81 | 2.41% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | ZAR 10.6B | ZAR 140.3B | ZAR 2,148.79 | 0.01% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | ZAR 11B | ZAR 85.8B | ZAR 493.05 | 2.71% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | ZAR 11.2B | ZAR 129.5B | ZAR 1,183.60 | 2.01% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | ZAR 11.2B | ZAR 167B | ZAR 1,104.73 | 2.20% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | ZAR 11.4B | ZAR 149.6B | ZAR 187.02 | 1.69% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | ZAR 12.3B | ZAR 155.7B | ZAR 1,639.61 | 1.40% up | 286% up | ||
| 28 | InsmedINSM · Health Care | ZAR 12.7B | ZAR 453.8B | ZAR 2,068.64 | 1.52% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | ZAR 13.3B | ZAR 111.4B | ZAR 2,743.48 | 0.91% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 13.6B | ZAR 354B | ZAR 2,642.90 | 2.03% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | ZAR 15.1B | ZAR 147.1B | ZAR 5,263.91 | 0.10% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | ZAR 17.3B | ZAR 54.2B | ZAR 279.50 | 0.65% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | ZAR 17.5B | ZAR 103.4B | ZAR 5,166.78 | 2.02% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | ZAR 31.4B | ZAR 135.2B | ZAR 804.29 | 2.66% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | ZAR 57.4B | ZAR 587.9B | ZAR 1,446.98 | 0.56% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 69.2B | ZAR 215.3B | ZAR 258.30 | 1.32% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 74.4B | ZAR 269.7B | ZAR 4,201.92 | 1.27% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | ZAR 75.2B | ZAR 796.6B | ZAR 6,973.67 | 2.10% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | ZAR 78B | ZAR 485.1B | ZAR 669.49 | 0.34% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | ZAR 100.8B | ZAR 546.8B | ZAR 886.86 | 0.98% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | ZAR 100.8B | ZAR 100.4B | ZAR 147.46 | 0.87% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 104.9B | ZAR 201B | ZAR 1,037.51 | 2.87% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | ZAR 112.9B | ZAR 227.6B | ZAR 455.41 | 2.21% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | ZAR 122.3B | ZAR 421.6B | ZAR 9,899.61 | 1.68% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 136.3B | ZAR 853.2B | ZAR 731.20 | 0.47% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | ZAR 167.5B | ZAR 679.3B | ZAR 1,181.44 | 0.20% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | ZAR 253.6B | ZAR 409.8B | ZAR 357.41 | 1.39% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | ZAR 318.4B | ZAR 2.11T | ZAR 1,032.51 | 2.36% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 321.7B | ZAR 2.34T | ZAR 9,220.54 | 0.13% up | 27% up | ||
| 50 | GSKGSK · Health Care | ZAR 374.7B | ZAR 1.69T | ZAR 842.38 | 0.75% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | ZAR 457.4B | ZAR 21.33T | ZAR 23,948.39 | 1.85% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | ZAR 496.4B | ZAR 3.02T | ZAR 685.27 | 2.32% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 538.8B | ZAR 1.7T | ZAR 16,473.46 | 0.22% down | 36% up | ||
| 54 | NovartisNVS · Health Care | ZAR 795.2B | ZAR 5.09T | ZAR 2,694.35 | 1.77% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | ZAR 802B | ZAR 1.18T | ZAR 368.45 | 1.22% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | ZAR 838.9B | ZAR 4.79T | ZAR 3,086.59 | 1.76% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | ZAR 898.6B | ZAR 3.11T | ZAR 1,795.00 | 0.55% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | ZAR 906.8B | ZAR 5.93T | ZAR 2,406.15 | 2.64% down | 51% up | ||
| 59 | SanofiSNY · Health Care | ZAR 1.37T | ZAR 1.96T | ZAR 815.15 | 0.50% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | ZAR 1.41T | ZAR 11.42T | ZAR 4,743.52 | 1.26% down | 38% up | ||
| 61 | PfizerPFE · Health Care | ZAR 1.49T | ZAR 2.77T | ZAR 485.66 | 1.04% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2372 ZAR).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-ZAR 56.4B), BridgeBio Pharma (-ZAR 36B) and Cytokinetics (-ZAR 11.4B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of ZAR 87.67T as of 18 Nov 2026, 16:06 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.